Transcript Highlights:

• It allows for CGMs to be billed by both pharmacy and durable medical equipment providers.
• Pharmacy and durable medical equipment providers. It is already live with our system.
• So my understanding, you correct me, I hope, is that it's instantaneous basically for pharmacy.
• We're also setting up a process by which we allow the pharmacy alert the pharmacy that they cannot bill
• And now what you're saying is they're going to go through pharmacy for these.

Summary: The committee reviewed a series of Arkansas DHS and Department of Health rules, most tied to 2025 legislation. Early items covered Medicaid changes including presumptive eligibility application timing, adding a fictive kin definition for foster child eligibility, raising the able account disability onset age to 46, allowing continuous glucose monitors to be billed by both pharmacy and DME providers, increasing the RSV vaccine administration fee for children, a telemedicine exemption for ET3 ambulance services, and a physical therapy access rule that also included occupational therapy. Members generally asked limited questions and most rules were reviewed without objection. A major portion of the meeting focused on the dental rate increase rule under Act 1025. DHS said it implemented rate increases for certain pediatric, special-needs, and oral surgeon services, but not orthodontics, and it interpreted the act as applying only to oral and maxillofacial surgeons, not general dentists. The Arkansas State Dental Association and legislative sponsors testified that the intent was to cover general dentists performing oral surgery procedures for special-needs patients, estimating the broader interpretation would add about $1.5 million annually. Committee members debated the plain language of the act versus legislative intent, and the rule was reviewed, but with testimony noting the issue should be fixed in future legislation. Later items included the Healthy Moms, Healthy Babies rule adding doula and lactation consultant billing and remote monitoring benefits; an adverse decisions rule extending provider appeal time from 35 to 65 days; CNA training program updates; PASSE network-status disclosure rules; certification rules for community-based doulas and community health workers; cosmetology, massage therapy, lead-based paint, radiation, radiologic technology, and RV park rule updates. Most of these were described as technical, statutory, or federally driven changes and were reviewed without objection. The committee briefly reopened the CGM rule after a motion to expunge the prior vote, and Representative Wardlaw said he would hold the rule for further review because he believed the billing changes did not match the law’s intent. The meeting ended with no further business and adjournment.

Transcript Highlights:

• benefit manager from paying its affiliated pharmacies more than non-affiliated pharmacies.
• Additionally, it prohibits them from paying their own pharmacies more than they pay the pharmacies in
• what the patients will pay at each pharmacy and what each pharmacy will be reimbursed for that drug.
• Local pharmacies are However, PBMs don't treat all of their in-network pharmacies the same.
• I own White Mountain Pharmacy in Show Low and another remote dispensing pharmacy in Overgaard.

Bills: SB1052, SB1115, SB1118, SB1120, SB1121, SB1124, SB1171, SB1172, SB1174, SB1175, SB1214, SB1233, SB1235, SB1316, SB1345, SB1372, SB1399, SB1458, SB1494, SB1496, SB1564, SB1602, SB1621, SB1628, SB1630, SB1631, SB1668, SB1672, SB1814, SB1821

Keywords: assisted living, health care, hyperbaric oxygen therapy, physician orders, informed consent, AHCCCS, remote work, state agency, employment, public health, housing, zoning, middle housing, urban development, duplexes, triplexes, fourplexes, townhomes, historic preservation, radiation protection

Transcript Highlights:

• Um, pharmacy inspection. So we have three pharmacy inspectors.
• ,<00:13:07.519> you'll we are the board of pharmacy, you'll we are the board of pharmacy,
• I will say the regulation of the pharmacy board is not necessarily connected to the pharmacy benefit
• > were<00:21:41.039> were The pharmacy benefit managers were were The pharmacy benefit
• > the<00:22:00.320> pharmacy<00:22:00.720> benefit connected to the pharmacy benefit

Keywords: 1189, house, all

Summary: The committee first approved the minutes from its October 3 meeting unanimously. It then reviewed follow-up status on prior performance audits, beginning with the Department of Corrections’ sex offender treatment program. DOC said all audit items from the 2016 review were resolved except one related to tracking benchmarks, progress, and recidivism. Officials explained that a new offender management system, Chorus, was recently implemented but has had rollout problems affecting operations, including restitution checks, and that they hope the system will be stable enough within about six months to begin tracking the needed metrics. Members asked about treatment inside prison and after release; DOC described in-prison treatment, parole aftercare, probation and parole oversight, administrative restrictions, and reassessment if conditions are not met. The committee next heard from OPLC on the Real Estate Commission audit. OPLC reported that all but one finding is substantially or fully resolved, with the remaining issue involving review of applicants’ adverse financial history and liabilities. The delay is tied to ongoing rulemaking, and OPLC said the commission is amending its criteria and integrating universal application procedures into board rules. The office estimated substantive completion by March 2027, with rule filing expected sooner. The committee then took up the Board of Pharmacy audit, where OPLC said most findings remain partially resolved because the board is in the middle of a major rule overhaul and a new licensing software project. Officials described a shift toward a compliance bureau and more routine, risk-informed inspections, rather than inspections driven only by complaints, and said updated manuals and forms will follow the new rules and technology. Finally, the Legislative Budget Assistant reported on ongoing audits. For special education, staff said they are writing the report, have 25 completed observations, and have expanded to 70 identified observations, with a full draft expected in the first quarter of 2026 and a final report by summer 2026. For education freedom accounts, 40 observations have been identified, 15 finalized, and a draft is expected by midspring with a fiscal committee presentation in summer. For the Doorway program, the audit plan was finalized with DHHS help, financial activity was isolated, fieldwork is expected to finish by Thanksgiving, and a draft report is planned for January or February 2026, with a final report by March or April 2026. The committee discussed scheduling its next meeting for February 6 at 10 a.m. and emphasized the value of follow-up on older audits; the meeting adjourned after members agreed the follow-up process should continue.

Transcript Highlights:

• PBMs own health plans, the pharmacy down the street, the mail-order pharmacy to where they steer patients
• pharmacies to close.
• Even before the Rite Aid closures, numerous community pharmacies were closing, creating pharmacy deserts
• and chain pharmacies and affiliate pharmacies.
• How those reimbursement rates differ between independent pharmacies and chain pharmacies and affiliate

Summary: The committee heard testimony on several bills, beginning with SB 41 by Senator Wiener, which would regulate pharmacy benefit managers by increasing transparency, banning patient steering and spread pricing, and requiring full pass-through of rebates. Supporters, including independent pharmacists and health advocates, said PBM practices are driving up drug costs and closing neighborhood pharmacies. Opponents from PBM and health plan groups argued the bill overlaps with recently enacted licensing and reporting requirements, would not lower consumer prices, and may be preempted by ERISA. Members discussed confidentiality issues, consumer savings, and the relationship between SB 41 and the new budget trailer bill; the author asked for an aye vote. The committee then took up SB 378, also by Senator Wiener, aimed at online marketplaces that advertise illegal intoxicating hemp and unlicensed cannabis products. Supporters from labor, public health, and the licensed cannabis industry said online sales are undermining regulated businesses and exposing children to unsafe products. Opponents from tech and hemp industry groups warned the bill is overbroad, could sweep in general-purpose platforms and lawful hemp wellness products, and raises Dormant Commerce Clause and First Amendment concerns. The author said he would narrow the bill, remove industrial hemp references, and address strict liability and standing issues; members largely focused on how to target illegal products without capturing lawful marketplaces. SB 243 by Senator Padilla addressed AI companion chatbots, with supporters including Common Sense Media and transparency advocates warning that these systems can be addictive, manipulative, and dangerous for minors and vulnerable users, citing studies and the death of a Florida teenager. The bill would require disclosures, anti-addiction design limits, self-harm protocols, audits, reporting, and a private right of action. Tech and business groups opposed the measure as overly broad and said its definitions could sweep in general-purpose AI tools; several members supported the goal but questioned the breadth of the definitions and the private right of action. Finally, SB 522 by Senator Wahab would extend just-cause eviction protections to rental units that were previously covered by the Tenant Protection Act but were destroyed in disasters and later rebuilt. Supporters, including Los Angeles city officials and tenant advocates, said the bill would help keep displaced renters housed after wildfires and other disasters. Apartment and realtor groups opposed it, arguing it would remove a key exemption needed to finance rebuilding and could discourage post-disaster reconstruction. Members expressed support for tenant protections in disaster areas, and the author asked for an aye vote.

Transcript Highlights:

• We can track pharmacies, but the pharmacies are not the ones filling the prescriptions; the pharmacists
• and a pharmacy is supposed to be secure from outside entities.
• : it controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities
• : it controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities
• controls pharmacies, but you have pharmacies within assisted living facilities or nursing facilities

Keywords: 1182, all

Transcript Highlights:

• This instrument provides relative to pharmacy benefit managers to provide for definitions.
• Thus streamlining the process for pharmacy appeals.
• It prohibits using a formulary to ban the use of certain pharmacies by an enrollee.
• It prohibits using formulary to ban the use of certain pharmacies by an enrollee.
• Apeic effective rate pricing: pharmacies can't predict reimbursement.

Summary: The House Insurance Committee met on April 29 with a quorum present and took up several insurance and health care-related bills. SB 192, a dental reimbursement bill, was amended to allow dentists to opt in electronically to credit-card payment methods and to clarify applicability and effective date; it was reported as amended. SB 84 would require prostate cancer screening coverage for men over 40 under current clinical guidelines and prohibit cost-sharing; supporters from the American Cancer Society said Louisiana has a high incidence of prostate cancer and that out-of-pocket costs deter early screening. The committee adopted amendments and reported the bill as amended. SB 275, dealing with reimbursement and network participation for certified registered nurse anesthetists, drew support from nursing and hospital groups and was reported favorably. SB 169, a cleanup bill on biomarker testing, was also amended and reported. The committee spent substantial time on SB 401, which creates a temporary prescription drug affordability board to review pricing data on selected drugs and report findings to the legislature. Supporters said the board would improve transparency and help lawmakers understand drug pricing trends; opponents raised concerns about confidentiality, market effects, and the lack of a defined policy outcome beyond reporting. Amendments narrowed the scope, added confidentiality protections, and removed opposition cards, and the bill was reported as amended. SB 387, a major PBM reform bill tied to SB 401, would change PBM compensation, rebate handling, formulary practices, audits, and appeals, while excluding ERISA plans after discussion and amendment. Supporters argued it would curb spread pricing and other practices that raise costs, while opponents from the Pelican Institute and PCMA warned it would interfere with private contracts, reduce flexibility, and could raise premiums or disrupt city, school board, and small-group plans. After extensive debate and a roll call, SB 387 was reported with amendments by a 10-4 vote. The committee also considered SB 241, which requires certain insurance adjusters and public adjusters to include license numbers in written communications. After amendments limiting the requirement to individual licenses and removing one statutory reference, the bill was reported as amended. Throughout the meeting, members and witnesses repeatedly discussed the need for transparency in drug pricing and PBM practices, the role of ERISA and non-ERISA plans, and potential impacts on public employers and consumers.

Transcript Highlights:

• <00:40:09.960> my insulin to our contract pharmacies my insulin to our contract pharmacies
• ship it there we have only one Pharmacy ship it there we have only one Pharmacy on<00:40:35.640>
• managed list of practicing pharmacy managed list of practicing pharmacy technicians<00:50:32.119
• <00:51:55.960> um so I could get home to my Pharmacy um so I could get home to my Pharmacy
• licensed pharmacists our pharmacy licensed pharmacists our pharmacy technicians<00:52:51.760>

Keywords: 910, house, all

Summary: The joint hearing covered HB 553 on biomarker testing coverage, HB 556 on colorectal cancer screening access, and later HB 712 on 340B drug pricing. For HB 553, the American Cancer Society Cancer Action Network, patient advocates Natalie Heyman and Susan Hirano, a surgical oncologist, and the American Lung Association strongly supported the bill, arguing that biomarker testing should be covered when ordered by a doctor and guided by current evidence. DHS and several insurers offered comments and requested amendments, with DHS saying it appreciated the intent but wanted changes. The committees then voted to pass HB 553 with amendments, including a House draft and a defective date of July 1, 3000; both the House Health and Human Services and Homelessness committees adopted the recommendation unanimously. For HB 556, testimony focused on closing gaps in colorectal cancer screening, especially for uninsured and underinsured patients who can get stool-based screening but then cannot access follow-up colonoscopies. Community Clinic of Maui, ACS CAN, and the American Cancer Society supported the bill, with ACS CAN urging a program similar to the breast and cervical cancer control program and offering amendments. DHS requested that the program and appropriation not conflict with executive budget priorities, and the committees noted technical amendments, a defective date, a blank appropriation amount, and corrections changing Medicare references to Medicaid. HB 556 was also passed with amendments by both committees. The hearing then moved to HB 712 on 340B drug pricing and contract pharmacies. The Department of Health and the Attorney General’s office expressed concern that the bill would require the state to regulate private commercial activity and said the department lacked the expertise and resources to implement it as written, suggesting it might belong in a different statutory section. In contrast, PhRMA opposed the bill, while Hawaii Pacific Health and Hawaii Island Community Health Center supported it, saying 340B savings are important for hospital services and patient access to low-cost medications, especially where manufacturers have restricted shipments to contract pharmacies. No vote on HB 712 was taken in the portion provided.

Transcript Highlights:

• We're also looking at pharmacy benefit managers, so PBM, pharmacy benefit managers, cost controls, and
• Five states have a pharmacy carve-out for managed care.
• It basically took out a lot of our pharmacies, our mom-and-pop pharmacies.
• And one of the pharmacies that also closed off was Rupi's Drug.
• You talked about pharmacies. Tell us about how it affected patients.

Transcript Highlights:

• So once they are in the pharmacy, that’s going to be the Board of Pharmacy.
• In the Pharmacy Act, in 0.056, it says specifically that a pharmacy.
• So we do respect our pharmacy colleagues.
• It's the pharmacy, Board of Pharmacy.
• If a minor goes up to the pharmacy...

Bills: HB 265, HB25

Keywords: youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting, child neglect, mandatory reporting, background check, criminal history check, sex offender registry, CPR training, first aid, public health, child protection, camp operator, camp counselor, Health and Safety Code

Transcript Highlights:

• As Chair Beerman pointed out, we did some phenomenal work with hospitals and pharmacy this year.
• Chair Berman replied that the directed pharmacy payment will not need federal approval.
• It will limit the pharmacies to non-PBM-owned pharmacies.
• , directed pharmacy dispensing payment, how<00:14:14.240> that<00:14:14.480> works,<00:
• It will limit the pharmacies to non-PBM-owned pharmacies.

Bills: HF2436, HF2435

Keywords: child welfare, economic assistance, child care, grant program, video security cameras, healthcare, dementia services, public health funding, opioid prevention, women's health, community health boards, mental health, 1183, house

Transcript Highlights:

• Leveraging the accessibility of pharmacies and the broad pharmacy network across our rural state, these
• Leveraging the accessibility of pharmacies and the broad pharmacy network across our rural state, these
• It's the pharmacy benefit managers by controlling the money.
• can't have... ...pharmacy now and I said, I lost my insurance.
• The system, as it currently is, is pharmacy benefit managers decide.

Keywords: 908, all

Summary: The committee first took up Senate Bill 2401, which would require physicians to complete continuing education on nutrition and metabolic health as part of the state’s rural health transformation effort. HHS supported the bill, saying it would help physicians better address chronic disease and preserve federal grant points tied to the state’s application. A member of the public also testified in favor, arguing that better nutrition education could improve diabetes outcomes and reduce costs. The committee then adopted an amendment to add the Board of Occupational Therapy Practice to the background-check statute so the occupational therapy compact could proceed, and it passed the bill as amended on a roll call vote. The committee next heard House Bill 1621, which would require the Presidential Fitness Physical Fitness Test in elementary, middle, and high school physical education courses. HHS said the bill was part of the rural health transformation application and could help preserve federal funding, but members raised many questions about the test’s criteria, adaptive options for students with disabilities, equipment needs, and whether the bill should apply to non-public schools. Senator Clemens offered an amendment to limit the requirement to public schools, but it failed. Senator Hogan then offered an amendment to clarify exemptions and allow DPI to align implementation with federal guidance; that amendment passed. A further amendment adding language allowing DPI to establish criteria for and exceptions to the test also passed. The committee then approved the bill as amended on a roll call vote. The committee also considered House Bill 1622, which joins North Dakota to the physician assistant licensure compact. HHS said the compact would improve access to care, especially in rural areas, support military families, and help preserve rural health transformation funding. Members noted the compact had been discussed in a prior session and that many earlier concerns had been resolved. After brief discussion about the compact process and its consistency with other interstate compacts, the committee voted to do pass the bill. Finally, the committee began Senate Bill 2402, which expands pharmacists’ prescriptive authority and therapeutic substitution powers. HHS and the Board of Pharmacy supported the bill as a way to improve access to care and maintain rural health transformation funding. Senator Roers introduced a detailed amendment negotiated with the Board of Medicine and Board of Pharmacy to narrow and clarify the bill, including notification requirements, limits on certain drug categories, and patient-protection language for therapeutic substitution. The Board of Pharmacy then testified in support of the broader bill and explained the CLIA-waived testing provisions and the repeal of the older, narrower pharmacist-testing language. The hearing and amendment discussion were still underway when the transcript ended.

Transcript Highlights:

• Item number two is the December 2025 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Moving to the February 2026 pharmacy formulary recommendations.
• more than we're paying our independent pharmacies within the plan?

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several Employee Benefits Division (EBD) and pharmacy formulary actions. Grant Wallace, director of EBD and the Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop the third-party administration RFP, and the committee approved it. The committee also approved the December 2025, January 2026, and February 2026 pharmacy formulary recommendations, along with February 2026 medical drug recommendations. The formulary changes focused on removing prior authorization for injectable migraine CGRPs, replacing a discontinued capsule with a tablet, updating items for FDA guidance, and leaving some drugs not covered when lower-cost alternatives or insufficient efficacy data existed. For February 2026, EBD recommended removing Skyrizi and Renvoke in favor of lower-cost biosimilars and other alternatives, re-tiering several drugs to encourage generics, adding an anti-seizure medication developed by the Department of Defense, and adding a subcutaneous version of Keytruda for faster administration. The medical drug list similarly shifted toward biosimilars and aligned coverage for Skyrizi and Renvoke across pharmacy and medical settings. Members raised broader questions about the impact of new pharmaceutical discount programs such as Trump RX and Mark Cuban Cost Plus, as well as concerns about PBM compliance and whether Navitus might be violating state law or paying affiliate pharmacies more than independent pharmacies. Wallace said the new programs and their effects were still being studied, that EBD was working with Navitus to evaluate pricing opportunities, and that Navitus had said it was in compliance with Rule 118, though additional research and auditing were underway. All items were approved by voice vote, and the meeting adjourned after no further business.

Transcript Highlights:

• I'm the pharmacy director at DHS.
• We don't work for pharmacy plans.
• We often work with local pharmacies, especially independent pharmacies, to help them with their patients
• Um, but the reason operating pharmacy.
• So, they saw a by pharmacy students.

Keywords: 1183, house

Transcript Highlights:

• costs that are not a contract pharmacy costs that are not a contract pharmacy so<00:57:49.839>
• , more than one contract pharmacy.
• more than one contract pharmacy. more than one contract pharmacy.
• While it was not heard in pharmacy.
• from the pharmacy.

Keywords: 919, house, all

Summary: The committee first approved the March 11, 2026 minutes, then heard House File 4048, which would exempt chiropractors from Minnesota’s provider tax if they are no longer eligible to provide chiropractic benefits under Medicaid/MinnesotaCare. Representative Robbins said the bill corrects an unfair situation because chiropractors still pay the tax even though the benefit was eliminated. Testifiers from the Minnesota Chiropractic Association and a longtime chiropractor supported the bill, arguing that most chiropractors are small-business owners and should not pay a tax for services they can no longer provide. Several members said they supported restoring chiropractic coverage instead of changing the tax, and there was discussion about whether the tax applies to all providers and whether it is effectively passed on to patients. The committee adopted a motion to recommend HF 4048 to the Committee on Taxes. The committee then took up House File 3893, as amended, a bill to restrict artificial intelligence from engaging in psychotherapy or counseling with humans. The author and supporters said the bill is intended to prevent AI chatbots from posing as therapists or counseling vulnerable people, citing reports of suicides and other harms linked to chatbot interactions. The A2 amendment was adopted; the author said it reflected stakeholder concerns and added informed-consent language. Testifiers in support, including a psychologist and a suicide-prevention nonprofit leader, urged strong safeguards and said AI should not replace licensed professionals in crisis settings. Other testimony raised concerns about overbreadth and unintended effects. TechNet and a rural mental health provider said the bill should be narrowed so it applies to clinical therapy rather than wellness or educational tools, and should allow supervised AI uses such as transcription and administrative support. Members discussed rural access, existing licensing-board authority, privacy laws, and whether the bill should target AI companies directly rather than licensed clinicians. The transcript ends during continued discussion of HF 3893, with no final committee action shown in the excerpt.

Transcript Highlights:

• You had small rural pharmacies, and you had big, giant pharmacies.
• then you're going to have to deal with it as a rural pharmacy.
• The rural pharmacies and the small pharmacies didn't want to have to accept that lower price, and so
• To the point that, and I myself experience this, you can go to the pharmacy counter, not show your pharmacy
• medical and pharmacy.

Keywords: 1184, house, all

Transcript Highlights:

• <01:37:28.719> at made up of the College of Pharmacy at made up of the College of Pharmacy
• > testimony community pharmacy testim testimony community pharmacy testim testimony recently,<
• pharmacy or pharmacy services near it. pharmacy or pharmacy services near it.
• Medical Assistance Directed Pharmacy Medical Assistance Directed Pharmacy Payment<01:38:32.719><
• single PBM model or really a pharmacy single PBM model or really a pharmacy benefit<01:39:01.199

Keywords: 1187, senate, all

Transcript Highlights:

• We are the national trade association for pharmacy benefit managers, and pharmacy benefit managers are
• We are a pharmacy with rural rates, and so we are different than most pharmacies because we don't have
• any pharmacies that are near us.
• of their pharmacies.
• <02:55:35.479> benefit for regulation of Pharmacy benefit for regulation of Pharmacy benefit

Keywords: 910, house, all

Summary: The committee first took up SB 1494 on hearing aids. Testimony was generally supportive of expanding hearing-aid coverage, with the Insurance Division raising concern about possible federal defrayment issues, SHPDA supporting the goal of hearing augmentation, DCAB strongly supporting the bill as an important access issue, and health plans and insurers asking for amendments. Kaiser Permanente and the Hawaii Association of Health Plans requested changes to add a medical-necessity standard and clarify annual notice language, while HMSA suggested the proposal should be studied by the auditor. The chair noted concerns about federal preemption and the lack of an audit, and deferred the bill in favor of a related resolution calling for a study. The committee then heard SB 1448, an emergency appropriation for the Hawaii State Hospital. DAGS and the Department of Health supported the measure, with the hospital administrator saying the funding would improve the environment of care, support cleaning, and allow a third-party review of the building. Committee members questioned the size of the request and the status of litigation against the design-builder. Administration witnesses said they were pursuing a comprehensive study involving destructive testing, had made a demand on the design-builder to fund the study, and were using different processes than before. They also said the roof work would be handled through a separate CIP request. No final action was taken in the portion provided. The committee next heard SB 1432, relating to the future responsibilities of the Department of Health and land issues at Kalaupapa after the last patient dies. DOH supported the bill in part but said its long-term role would be limited mainly to environmental cleanup, with operations expected to continue under the National Park Service and land-use decisions left to DHHL and beneficiary consultation. DHHL asked that the measure reflect that any land-use or zoning changes on homeland lands require commission approval and beneficiary consultation. Testifiers from Kalaupapa and Maui County, including Degra Vanderbilt-Papa and Council Member Keani Rollins-Fernandez, supported deferring the bill, saying there had been no meaningful community discussion about provisions affecting Kalaupapa’s future management and possible transfer of responsibilities to Maui County. The committee also read into the record written testimony from Gloria Marks emphasizing that Kalaupapa stakeholders must be included in future discussions. Finally, the committee heard SB 955 on fitness-to-proceed examinations. The Judiciary and the Public Defender’s Office both supported raising pay and standardizing expectations for private examiners, but opposed reducing felony fitness evaluations from three examiners to one and opposed expanding use of expedited reports. They argued that a single examiner would reduce reliability, create a more adversarial process, and likely increase costs and contested hearings, while expedited reports do not contain enough information for a proper fitness determination. The Department of Health also supported the bill’s intent but asked to preserve a three-examiner framework and said the goal was to reduce the number of people sent to the State Hospital, where admissions have reportedly risen about 20% year over year since Act 26. The bill remained under discussion in the excerpt, with no final vote shown.

Transcript Highlights:

• James Kuski, Board of Pharmacy, and support.
• only get it at my one little pharmacy.
• only get it at my one little pharmacy.
• talking about are available at every pharmacy.
• talking about are available at every pharmacy.

Keywords: 912, senate, all

Summary: The joint Health, Human Services, and Labor and Technology committee heard testimony on SB 447, a Department of Health pilot program related to recruitment, and SB 1043, a tax measure. On SB 447, the Department of Health said the pilot had streamlined hiring by delaying minimum-qualification review until later in the process, while the Department of Human Resources Development objected that parts of the bill could conflict with civil service rules, due process rights, and equal pay requirements. Several labor and employee groups testified, with some supporting the pilot as a way to address vacancies and others warning about merit-system concerns. The committee later voted to pass SB 447 as is. On SB 1043, testimony was mixed but largely focused on the bill’s tax changes, especially the proposed increase to the general excise tax and exemptions or credits for lower-income households. Supporters, including labor groups and housing/worker advocates, argued the bill would reduce burdens on working families, help with food insecurity, and keep residents in Hawaiʻi. Opponents, including the Tax Foundation of Hawaiʻi and some community witnesses, said the general excise tax is regressive and would raise costs across the state. The committee voted to advance SB 1043 with substantial amendments, deleting most of the bill except section two and setting a far-future effective date, while noting the fiscal impact had not been provided. The committee also deferred SB 633 and later deferred SB 1633 for further decision-making, scheduling continued consideration for February 12, 2025, in Room 225. The hearing included standard instructions on one-minute testimony, written testimony, and Zoom procedures, and the committee adjourned after taking the above actions.

Transcript Highlights:

• First up, we have Alana Isobe, DCCA PVL, Board of Pharmacy, providing comments.
• ,<00:08:59.200> providing DCCAP PVL, Board of Pharmacy, providing DCCAP PVL, Board of Pharmacy
• Um, my name is Christopher Fernandez, executive officer for the Board of Pharmacy.
• <00:10:14.000> We're officer for the board of pharmacy.
• We're officer for the board of pharmacy.

Keywords: 912, senate, all

Summary: The HHS committee met in Room 224 and announced the hearing was being streamed live, with a one-minute limit on testimony. The chair explained that written testimony had already been reviewed and that speakers should either add new comments or stand on their written testimony. The committee first heard SB 2211, an emergency appropriation to the Department of Human Services. Testimony was overwhelmingly in support, including DHS, Aloha United Way, the Hawaii Food Industry Association, the Hawaii Public Health Institute, Catholic Charities, and many individuals. Supporters emphasized the importance of maintaining SNAP-related food assistance and emergency food delivery, while Catholic Charities raised a question about whether the bill’s language would also reach food banks serving food-insecure households that are not on SNAP. No opposition was heard and the bill was moved on without questions from members. The committee then heard SB 2025, which would exempt actively practicing advanced practice registered nurses from jury duty. Testimony was broadly supportive from nursing and health organizations, including the Hawaii American Nurses Association, the Hawaii affiliate of the College of Nurse Midwives, the Hawaii State Board of Nursing, and others. One witness from Kaiser Permanente requested an amendment to include physician assistants, and a committee member asked the Board of Nursing to review that request. The bill otherwise drew no opposition and no further member questions. SB 2038, relating to medication labeling, drew the most extended discussion. The measure would change labeling requirements for certain abortion medications, and testimony was split between supporters who framed it as a privacy and access issue and opponents who raised patient safety, ethics, and transparency concerns. The Department of Health supported the intent but requested an amendment to allow quicker access to private information during investigations without a subpoena. The Board of Pharmacy said it supported the written comments but noted operational challenges and possible cost impacts, while Kaiser said compliance would likely require manual workarounds and could slow pharmacy processes. The chair and members questioned whether patients could simply remove labels themselves, but witnesses said there could still be safety and access issues if the patient is not the one receiving the prescription. The committee then moved on to SB 2050, relating to chiropractic, which received support from the Hawaii Board of Chiropractic and the Hawaii State Chiropractic Association, with no substantive opposition noted. The hearing later turned to SB 201, relating to insurance, which appeared to be a new mandated-benefit measure tied to infertility/IVF coverage. The Hawaii Civil Rights Commission provided comments, while Hawaii Family Forum opposed the bill, arguing it went beyond medical infertility and raised ethical and public policy concerns. Kaiser and the Hawaii Association of Health Plans both asked for a study or audit, saying the measure could create new insurance mandates and increase costs for residents and employers. Private Work Hawaii strongly supported the bill as an equity issue. The committee noted there was no quorum for decision-making and deferred action on the measure to a later hearing, then recessed.

Transcript Highlights:

• , the same; the drug manufacturers, the same; the pharmacy benefit managers, the same; and the Pharmacy
• I know originally it was under the Board of Pharmacy, which I don't think anybody was happy with, and
• I'm Brendan Joyce with Medicaid, the pharmacy director.
• We are not the pharmacy experts, but we will certainly implement to the best of our ability if given
• I think if the intent is to look at the carriers, the PBMs, drug manufacturers, pharmacies, etc., we'd

Keywords: 908, all

Summary: The subcommittee met on SB 2370 with a quorum present and focused on how to handle proposed 340B-related reporting language. Members discussed three main paths: adopt the LC draft with reporting requirements for covered entities, PBMs, insurers, and manufacturers; convert only the PBM/insurer/manufacturer portions into a study; or turn the entire proposal into a study. Representative Dobervich explained that the study version would keep the same subject areas but delay initial reporting so the data could be analyzed more thoughtfully, and she noted gaps in the original amendments, including federally qualified health centers participating in 340B, 340B contract pharmacies, and a clearer plan for data analysis and administration. Testimony from HHS and the Insurance Department emphasized that collecting data is different from analyzing it and that any version would need clear authority, confidentiality protections, and a designated agency willing to collect, analyze, and publish the information. The Insurance Department said it could potentially collect data but would likely need additional budget resources for analysis, and it noted that the pending PBM bill, SB 1584, could affect what information is already available through regulation. A representative of the North Dakota Pharmacists Association said SB 1584 contains some reporting but is not as comprehensive as the proposal under discussion. Members also discussed whether the proposal belonged in an insulin bill at all, with concerns raised about germaneness and the possibility of sending the matter to the Delayed Bills Committee or placing study language elsewhere. No vote was taken. The subcommittee adjourned after members agreed to continue refining the language over the weekend and bring options back to the full committee, with several members expressing a preference for a combined version that includes both reporting and study elements.